TABLE 2.

Regional pseudo-SUVr of flutriciclamide in brain tissue regions for both the CCM and control group.

Non-CCM ROI	CCM	Control
Temporal pole	1.96 ± 0.25	1.81 ± 0.34
Cuneus	1.85 ± 0.32	1.53 ± 0.24
Paracentral lobule	1.64 ± 0.24	1.59 ± 0.23
Calcarine	1.64 ± 0.21	1.41 ± 0.13
Cerebellum_Crus1	1.83 ± 0.29	1.47 ± 0.28
Supp motor area	1.46 ± 0.25	1.42 ± 0.17
Vermis (1–10)	1.44 ± 0.28	1.19 ± 0.22
Amygdala	1.63 ± 0.22	1.39 ± 0.21
Frontal_Sup	1.30 ± 0.11	1.26 ± 0.12
Hippocampus	1.64 ± 0.16	1.34 ± 0.16
Cingulum_Post	1.41 ± 0.23	1.30 ± 0.09
Precuneus	1.60 ± 0.22	1.39 ± 0.14
Cerebellum (3–10)	1.42 ± 0.24	1.28 ± 0.18
Parahippocampus	1.56 ± 0.19	1.43 ± 0.15
Occipital sup	1.52 ± 0.15	1.36 ± 0.21

The striatum was selected as a pseudo-reference for SUVr.